NewsRoom Articles - Page 178 of 542

TuesdaySep 21, 2021 12:49 pm

Simply Sonoma Inc. Fits Organic Farming Bill, Different Kind of CBD Company

Natural farming is one of the solutions for mitigating the impacts of climate change, says article Simply Sonoma embodies the idea of organic farming in a way few other companies in the CBD space do From seed to sale, the company owns or contracts the organic grow, extraction and product formulation operations A recent MJBizDaily article touts the importance of organic farming, noting that “as the legal marijuana industry continues to expand, it’s urgent that we understand the consequences of placing too much reliance on large industrial cannabis grown indoors under artificial lighting.” A different kind of natural company, Simply…

TuesdaySep 21, 2021 4:20 am

420 with CNW — US Mayors’ Conference Urges Congress to Legalize Cannabis

The war on drugs has been declared an unmitigated failure — and for good reason. Prohibitionist policies left America’s jails filled with millions of individuals, many of them charged with relatively minor drug offenses, and minority communities were disproportionately targeted. Most states with legal cannabis markets have tried to correct these wrongs by giving these minority communities a leg up in the cannabis industry. Now, members of the U.S. Conference of Mayors are asking the Biden administration to do the same at the federal level. During its 89th annual meeting, the organization passed a comprehensive resolution urging President Joseph Biden and…

MondaySep 20, 2021 4:20 pm

420 with CNW — Experts Believe Federal Marijuana Legalization May Influence CBD Regulation by FDA

In 2018, the FDA approved CBD for use as an ingredient in Epidiolex, which is a prescription drug indicated for the treatment of severe epilepsy. Participants in the hemp industry have states that drug approval is what’s keeping the FDA from regulating CBD as a dietary ingredient or supplement. Minor cannabinoids may not face the same issues as CBD because they haven’t been approved as prescription medications. Many hope the FDA’s approach to major and minor cannabinoids will shift, depending on the laws that make marijuana legal on a federal scale. A few manufacturers and leaders involved in the hemp…

MondaySep 20, 2021 12:51 pm

RYAH Group Inc. (CSE: RYAH) Devices Ideal for Implementation of New Cannabis Intake Control Recommendations

Research team uses Delphi process for the first time to identify ideal cannabis dosing guidelines. After several rounds of voting, the ‘global task force’ created three separate dosing protocols. RYAH Group’s suite of precision dosing devices provide a practical way to safely execute these — or any — recommended dosing guidelines. Dosing recommendations are critical in any health treatments, but where cannabis is concerned, dosing levels have been tricky to identify. A recent blog from RYAH Group (CSE: RYAH) notes that a team of more than 20 cannabis experts have published consensus recommendations for dosing and administration of medical cannabis…

MondaySep 20, 2021 10:41 am

Sugarmade Inc. (SGMD) Ideally Positioned in Billion-Dollar Space ‘Ripe for Cannabis Delivery’

States that have already legalized cannabis are seeing a spike in business thanks to the overwhelming convenience of cannabis delivery Article reports that delivery services can “help surge revenue for retailers that jump in to take advantage” Earlier this year, SGMD launched a new business initiative for the licensed delivery of cannabis products According to a recent article, states that have already legalized cannabis, such as California, are seeing a spike in business thanks to the overwhelming convenience of cannabis delivery (https://cnw.fm/SrPtT). This is great news for Sugarmade (OTC: SGMD), an innovator in the dynamic California cannabis scene with majority…

MondaySep 20, 2021 4:20 am

420 with CNW — Why US Brands See Global Opportunities for CBD Beauty Products

After the 2018 Farm Bill legalized the cultivation and sale of industrial hemp and its derivatives, an industry swiftly sprang up around the product. Hemp is an extremely versatile product with a wide range of applications ranging from textiles and construction to health and wellness. Cannabidiol (“CBD”), a hemp extract said to have diverse medical capabilities, has attracted the bulk of the attention, and it is predicted to achieve $1.8 billion worth of sales in 2022. American companies are now looking to expand past the country's border as more countries around the world launch hemp programs. But thanks to nearly…

FridaySep 17, 2021 4:20 pm

420 with CNW — Federal Financial Regulator Criticizes Congress for Failing to Reform Marijuana Laws

Rodney Hood, the former chairman of the National Credit Union Administration (“NCUA”) has criticized Congress for failing to reform cannabis laws. The NCUA is an independent federal agency that offers deposit insurance to credit unions. Hood served as a regulator from 2005–09, before becoming chairman in 2019 and transitioning to a board position. The regulator announced last week at the PBC conference that he would be taking steps to push legislators to enact changes in policy that help stakeholders and financial institutions. He stated that he was concerned that the regulatory and legal infrastructure surrounding the marijuana industry wasn’t evolving…

FridaySep 17, 2021 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Signs Definitive Agreement to Acquire 100% of BayMedica Inc., Positioning it to Stand Distinct in Rare Cannabinoids Manufacturing, Become a Revenue-Generating Company, Expand Drug Development Capabilities

InMed Pharmaceuticals recently announced it has entered a definitive agreement to acquire 100% of BayMedica Inc. BayMedica is a private company that specializes in the manufacture and commercialization of rare cannabinoids Upon closing, the transaction will make InMed a global leader in the manufacturing of rare cannabinoids in addition to transforming it into a revenue-generating company Acquisition provides InMed with the complete flexibility across multiple manufacturing approaches On September 13, InMed Pharmaceuticals (NASDAQ: INM), a company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids, announced it has signed a definitive agreement to acquire 100% of BayMedica…

FridaySep 17, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Draws Closer to NDA Filing for DehydraTECH CBD

Lexaria just released the most important results yet from its ongoing HYPER-H21-2 human clinical trials on the effects of the company’s patented DehydraTECH(TM)-processed CBD on blood pressure Chris Bunka, Lexaria’s CEO, termed the results as “statistically significant” Participants in the study reported up to an average 23% decrease in blood pressure and a 7% drop in systolic pressure These results bring Lexaria closer to NDA filing with the FDA, making it a pioneer in CBD hypertension treatment Lexaria Bioscience (NASDAQ: LEXX) just released the most recent results from its ongoing HYPER-H21-2 human clinical trials on the effects of the company’s…

FridaySep 17, 2021 4:20 am

420 with CNW — National Hemp Association Requests $1B from Congress to Boost Industry Innovation

America’s hemp industry may be young, but it is brimming with potential just a couple of years after the 2018 Farm Bill legalized the cultivation and sale of hemp and its derivatives. But while the American hemp industry was valued at $5.66 billion in 2020 and is projected to see major growth over the next decade, it hasn’t received much government support. And given that hemp is a versatile product with a wide variety of applications ranging from cloth, cosmetics, and rope to printer's ink, wood preservative and a construction material called hempcrete, government investment could turn the nascent hemp…